Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease
AbstractFor the majority of patients diagnosed with celiac disease, once a gluten-free diet is initiated, symptoms improve within weeks and may completely resolve in months. However, up to 30% of patients may show signs, symptoms or persistent small intestinal damage after one year on a gluten-free diet. These patients require evaluation for other common GI etiologies and assessment of their celiac disease status in order to make a diagnosis and suggest treatment. Here, we propose an approach to evaluating patients with celiac disease with persistent symptoms, persistently elevated serology, and or persistent villous atrophy despite a gluten-free diet. We detail how to diagnose and distinguish between non-responsive and refractory celiac disease. Finally, we introduce the indications for use of the gluten contamination elimination diet and provide information for practitioners to implement the diet when necessary in their practice. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Leonard, M.M.; Cureton, P.; Fasano, A. Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease. Nutrients 2017, 9, 1129.
Leonard MM, Cureton P, Fasano A. Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease. Nutrients. 2017; 9(10):1129.Chicago/Turabian Style
Leonard, Maureen M.; Cureton, Pamela; Fasano, Alessio. 2017. "Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease." Nutrients 9, no. 10: 1129.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.